MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1002/pros.70128

Медицинская библиотека · The Prostate · 2026

Evaluation of Loss of the Y Chromosome in Peripheral Blood as a Biomarker for Prostate Cancer.

Lu Jun, Lu Yan, Kobayashi Takuro, Hachiya Tsuyoshi, Wakita Haruhiko, Jin Yiming, Tanaka Yasunari, Ikehata Yoshihiro, Nagata Masayoshi, Ide Hisamitsu, Horie Shigeo

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Prostate cancer (PCa) is the most common malignant tumor in men, but the widely used prostate-specific antigen (PSA) test has limited diagnostic accuracy. Research proposes that the loss of the Y chromosome (LOY) may affect the occurrence and development of prostate cancer, aiming to assess its potential as a diagnostic biomarker to improve the accuracy of prostate cancer detection and clinical management.

METHODS

LOY levels were measured using droplet digital polymerase chain reaction (ddPCR) method, integrating relevant clinical indicators to evaluate the potential clinical significance of LOY in PCa. Logistic regression was employed to estimate risk prediction capability of LOY, and model performance was validated through bootstrapping.

FINDINGS: 131 men patients were enrolled in this study whose PSA level exceeding 4.0 ng/ml and underwent prostate biopsies. According to post-biopsy pathological results, subjects were classified into normal and cancer groups. LOY levels were significantly higher in the cancer group than in the normal group (p < 0.001). LOY levels show a consistent increase with advancing AJCC clinical stage and escalating PI-RADS scores. LOY is a promising biomarker for PCa (AUC = 0.898). Clinical decision curve analyzes demonstrated that incorporating LOY into each conventional model provided greater clinical benefit compared with the original model.

INTERPRETATION: In biopsy patients, the LOY levels in the cancer group were higher than those in the normal group, and this was more pronounced in patients at advanced clinical stages. LOY levels have strong diagnostic efficacy for PCa, indicating that LOY may serve as an auxiliary biomarker for early PCa diagnosis.

Для цитирования: Lu Jun, Lu Yan, Kobayashi Takuro, Hachiya Tsuyoshi, Wakita Haruhiko, Jin Yiming, Tanaka Yasunari, Ikehata Yoshihiro, Nagata Masayoshi, Ide Hisamitsu, Horie Shigeo. Evaluation of Loss of the Y Chromosome in Peripheral Blood as a Biomarker for Prostate Cancer.. The Prostate. 2026. DOI: 10.1002/pros.70128.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.